Ligand Pharmaceuticals logo

Ligand Pharmaceuticals

LGNDNASDAQ

Ligand Pharmaceuticals is a biotechnology company in the healthcare sector on NASDAQ, led by John L. Higgins, with a market cap of $3.7B. As of Q3 2025, 106% of shares are held by 306 institutional investors, with BlackRock, Inc. as the largest holder at 14.8%.

Chief Executive OfficerJohn L. Higgins
Market Cap$3.7B
Biotechnology
Healthcare
Employees58.0
Websiteligand.com
Country
United States of America

Overview

Overview of institutional ownership in LGND as of Q3 2025 with a market cap of $3.5B

All Institutions

Institutions
306
Value Held
$3.6B
Shares Held
20.6M
Avg Position
$11.9M
Median Position
$838.2K

Hedge Funds

Hedge Funds
23
Value Held
$143.5M
Shares Held
810.1K
Avg Position
$6.2M
Median Position
$1.5M

Ownership Breakdown

Institutional (non-HF): 101.50%Institutional (non-HF)Hedge Funds: 4.16%Retail & Other: -
Institutional (non-HF)
101.5%
$3.5B
Hedge Funds
4.16%
$143.5M
Retail & Other
-
-

Based on market cap of $3.5B as of Q3 2025. Institutional (non-HF) excludes hedge funds to avoid double counting.

Biggest Investors

Institutions with the largest positions in LGND as of Q3 2025

InstitutionPosition Value
B
BlackRock, Inc.
Institution
$511.0M
0.01% of portfolio
$367.8M
0.01% of portfolio
$184.6M
0.08% of portfolio
$133.2M
0.16% of portfolio
$132.7M
0.00% of portfolio
$118.2M
0.79% of portfolio
$100.7M
2.48% of portfolio
$98.2M
1.27% of portfolio
$96.0M
0.03% of portfolio
$92.8M
0.02% of portfolio

Net Capital Flow

Institutional buying and selling activity for LGND in Q3 2025

Traded
+$273.0M
Buyers
163
Sellers
115
Total Bought
+$474.9M
Total Sold
$202.0M
Avg Position
$11.3M

Biggest Buyers

InstitutionNet Bought
FMR LLC logo
FMR LLC
Institution
+$76.3M
+431.0K shares
+$53.9M
+304.1K shares
+$39.3M
+222.0K shares
+$35.8M
+202.1K shares
Invesco Ltd. logo
Invesco Ltd.
ETF Provider
+$26.3M
+148.4K shares
+$21.5M
+121.4K shares
+$21.3M
+120.0K shares
+$18.1M
+101.9K shares
TUDOR INVESTMENT CORP ET AL logo
TUDOR INVESTMENT CORP ET AL
Hedge FundMulti-Strategy
+$17.7M
+99.9K shares
+$16.8M
+94.9K shares

Biggest Sellers

InstitutionNet Sold
$32.0M
180.6K shares
$31.0M
174.8K shares
$11.1M
62.8K shares
$10.6M
60.0K shares
$10.3M
58.1K shares
$8.9M
50.3K shares
$7.6M
42.9K shares
$7.0M
39.5K shares
$6.2M
35.1K shares
B
BlackRock, Inc.
Institution
$5.2M
29.2K shares

Entry and Exit Activity

Institutions that initiated new positions or completely exited LGND in Q3 2025

New Positions
26
New Value
$10.1M
Exited Positions
16
Exited Value
$3.1M

New Positions

InstitutionPosition Value
$2.6M
14.5K shares
PIER 88 INVESTMENT PARTNERS LLC logo
PIER 88 INVESTMENT PARTNERS LLC
Hedge FundLong/Short
$1.3M
7.2K shares
$839.5K
4.7K shares
E
EntryPoint Capital, LLC
Hedge FundLong/Short
$533.0K
3.0K shares
$499.5K
2.8K shares
$442.9K
2.5K shares
Quantinno Capital Management LP logo
Quantinno Capital Management LP
Hedge FundMarket Neutral
$440.0K
2.5K shares
$372.9K
2.1K shares
N
NORDEN GROUP LLC
Institution
$371.1K
2.1K shares
B
Baader Bank INC
Institution
$361.1K
2.1K shares

Exited Positions

InstitutionPrevious Position
$833.3K
7.3K shares
$676.5K
6.0K shares
$484.2K
4.3K shares
TWEEDY BROWNE CO LLC// logo
TWEEDY BROWNE CO LLC//
Long Only Manager
$357.0K
3.1K shares
$357.0K
3.1K shares
Advantage Alpha Capital Partners LP logo
Advantage Alpha Capital Partners LP
Hedge FundMarket Neutral
$207.2K
1.8K shares
Q
Quarry LP
Institution
$113.6K
999.0 shares
$37.5K
330.0 shares
$20.7K
182.0 shares
$13.5K
119.0 shares

Options Activity

Institutions with the largest Call and Put options positions in LGND as of Q3 2025

Call Positions
4
Call Value
$3.4M
Put Positions
2
Put Value
$2.0M

Call Positions

InstitutionPosition Value
$1.6M
90.0 contracts
CITADEL ADVISORS LLC logo
CITADEL ADVISORS LLC
Hedge FundMulti-Strategy
$1.2M
68.0 contracts
$283.4K
16.0 contracts
$283.4K
16.0 contracts

Put Positions

InstitutionPosition Value
$1.7M
96.0 contracts
$336.6K
19.0 contracts

Most Committed Institutions

Institutions with LGND as the highest % of their portfolio as of Q3 2025

InstitutionPortfolio Weight
4.89%
$49.6M
4.82%
$43.3M
4.08%
$40.2M
3.40%
$48.8M
2.84%
$52.2M
2.48%
$100.7M
1.66%
$10.8M
1.53%
$2.4M
1.46%
$19.0M
PIER 88 INVESTMENT PARTNERS LLC logo
PIER 88 INVESTMENT PARTNERS LLC
Hedge FundLong/Short
1.35%
$1.3M

Hedge Fund Spotlight

Discover hedge funds investing in LGND

E
EntryPoint Capital, LLC
Hedge FundLong/Short
Portfolio ManagerLawrence Edward Leibowitz
Portfolio Value
$258.4M
Positions
644
Last Reported
Q3 2025
AddressNew York, NY
Sector Allocation
Financial Services: 19.00%Financial ServicesIndustrials: 16.30%IndustrialsTechnology: 12.70%TechnologyHealthcare: 10.30%HealthcareConsumer Cyclical: 9.90%Consumer CyclicalReal Estate: 7.80%Basic Materials: 4.70%Utilities: 4.70%Consumer Defensive: 4.30%Energy: 3.80%Communication Services: 2.80%
Ligand Pharmaceuticals logo

Position in Ligand Pharmaceuticals

Market Value
$533.0K
Shares Held
3.0K
Portfolio Weight
0.21%
Owned Since
2025-Q3
Top HoldingSectorMarket ValueWeight
Telecommunications Services
Communication Services
$1.5M0.60%
Education & Training Services
Consumer Defensive
$1.5M0.58%
Hardware, Equipment & Parts
Technology
$1.5M0.56%

Cookie Preferences

We use cookies for analytics. See our Privacy and Cookie Policy.